|
|
|
|
| LEADER |
00000cam a22000002 4500 |
| 001 |
1091133816 |
| 003 |
DE-627 |
| 005 |
20230427063757.0 |
| 007 |
tu |
| 008 |
900726s1984 xx ||||| t 00| ||eng c |
| 035 |
|
|
|a (DE-627)1091133816
|
| 035 |
|
|
|a (DE-576)021133816
|
| 035 |
|
|
|a (DE-599)BSZ021133816
|
| 035 |
|
|
|a (OCoLC)311291735
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 088 |
|
|
|a SCNAC-98-1-6
|
| 245 |
1 |
0 |
|a Federal drug strategy
|b 1983; hearings before the Select Committee on Narcotics Abuse and Control, House of Representatives, 98. Congress, 1. session, Nov. 1 and 2, 1983
|
| 264 |
|
1 |
|a Washington, D.C.
|b U.S. GPO
|c 1984
|
| 300 |
|
|
|a III, 403 S.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
| 655 |
|
7 |
|a Forschungsbericht
|0 (DE-588)4155043-2
|0 (DE-627)10467444X
|0 (DE-576)209815833
|2 gnd-content
|
| 710 |
2 |
|
|a USA
|b Congress
|b House of Representatives
|b Select Committee on Narcotics Abuse and Control
|0 (DE-588)1048583-1
|0 (DE-627)100142443
|0 (DE-576)191429007
|4 oth
|
| 951 |
|
|
|a BO
|
| ELC |
|
|
|b 1
|
| LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
| LOK |
|
|
|0 001 2148292005
|
| LOK |
|
|
|0 003 DE-627
|
| LOK |
|
|
|0 004 1091133816
|
| LOK |
|
|
|0 005 19900726000000
|
| LOK |
|
|
|0 008 900726||||||||||||||||ger|||||||
|
| LOK |
|
|
|0 040
|a DE-21
|c DE-627
|d DE-21
|
| LOK |
|
|
|0 852
|a DE-21
|
| LOK |
|
|
|0 852 1
|c KB 7 E 267
|9 00
|
| LOK |
|
|
|0 935
|a krim
|
| LOK |
|
|
|0 936ln
|a k1
|
| ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
| SIG |
|
|
|a UB: KB 7 E 267
|
